Linzagolix Choline Powder
FDA Label NDC 62128-0395

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Evonik Corporation for the product Linzagolix Choline (NDC 62128-0395). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding shipping nicelabel dec2022, warehouse kg (put-away) label, elma, dec 2022, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.